Collectively our data show that at the late timepoint, when mice were sacrificed due to tumor burden, there was an increased survival of GBM-bearing mice associated with the partial removal of p16Ink4a senescent cells, therefore pointing to the tumor-promoting action of senescent cells during gliomagenesis. The gene discussed is CDKN2A; the disease is neoplasm.